SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS (STNF-R) AND HIV-INFECTION - CORRELATION TO CD8+ LYMPHOCYTES

被引:28
作者
KALINKOVICH, A
LIVSHITS, G
ENGELMANN, H
HARPAZ, N
BURSTEIN, R
KAMINSKY, M
WALLACH, D
BENTWICH, Z
机构
[1] HEBREW UNIV JERUSALEM,KAPLAN HOSP,SCH MED,R BEN ARI INST CLIN IMMUNOL,IL-76100 REHOVOT,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,DEPT ANAT & ANTHROPOL,IL-69978 TEL AVIV,ISRAEL
[3] WEIZMANN INST SCI,DEPT MEMBRANE RES & BIOPHYS,IL-76100 REHOVOT,ISRAEL
关键词
SOLUBLE TUMOR NECROSIS FACTOR RECEPTORS; HIV INFECTION; CD8+ LYMPHOCYTES;
D O I
10.1111/j.1365-2249.1993.tb08184.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to determine sTNF-R, type I (p55) and type II (p75) in sera of HIV-infected male homosexuals and correlate them to T lymphocyte subpopulations and course of HIV infection. Serum samples were obtained from 39 HIV-1+ asymptomatic male homosexuals, 10 symptomatic (ARC and AIDS) male homosexuals and 44 HIV- non-homosexual healthy controls. sTNF-R levels were determined by ELISA with specific MoAbs and polyclonal antibodies to the sTNF-R proteins. sTNF-RI and II levels were significantly elevated in 72% and 74% respectively of HIV+ asymptomatic male homosexuals and in all of the symptomatic male homosexuals. In sequential studies a highly significant positive correlation was found between sTNF-RI and sTNF-RII (r=0.8, P<0.001) and between both sTNF-R and CD8+ lymphocyte counts (r=0.6 and 0.92, respectively, P<0.01-0.001) during the asymptomatic stage of the infection. All these correlations were lost, however, during the symptomatic phase of the disease. These results suggest that: (i) HIV infection is associated with elevation of sTNF-R serum levels; (ii) sTNF-R levels are strongly correlated to CD8+ lymphocytes during the asymptomatic stage of HIV infection.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 58 条
  • [51] TOMKINSON BE, 1989, J IMMUNOL, V142, P2230
  • [52] VANDERPOLL T, 1992, EUR CYTOKINE NETW, V3, P214
  • [53] SUBSET MARKERS OF CD8(+) CELLS AND THEIR RELATION TO ENHANCED CYTOTOXIC T-CELL ACTIVITY DURING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    VANHAM, G
    KESTENS, L
    PENNE, G
    GOILAV, C
    GIGASE, P
    COLEBUNDERS, R
    VANDENBRUAENE, M
    GOEMAN, J
    VANDERGROEN, G
    CEUPPENS, JL
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (06) : 345 - 356
  • [54] TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTORS CIRCULATE DURING EXPERIMENTAL AND CLINICAL INFLAMMATION AND CAN PROTECT AGAINST EXCESSIVE TUMOR-NECROSIS-FACTOR-ALPHA INVITRO AND INVIVO
    VANZEE, KJ
    KOHNO, T
    FISCHER, E
    ROCK, CS
    MOLDAWER, LL
    LOWRY, SF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 4845 - 4849
  • [55] INTERFERON-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN SERUM OF PATIENTS IN VARIOUS STAGES OF HIV-1 INFECTION
    VONSYDOW, M
    SONNERBORG, A
    GAINES, H
    STRANNEGARD, O
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (04) : 375 - 380
  • [56] WATRET KC, 1993, CLIN EXP IMMUNOL, V92, P93
  • [57] YAGI MJ, 1992, CLIN IMMUNOL IMMUNOP, V63, P1216
  • [58] QUANTITATION OF BETA-2-MICROGLOBULIN AND OTHER IMMUNE CHARACTERISTICS IN A PROSPECTIVE-STUDY OF MEN AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME
    ZOLLAPAZNER, S
    WILLIAM, D
    ELSADR, W
    MARMOR, M
    STAHL, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (22): : 2951 - 2955